Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penthrox versus intravenous morphine for fracture pain in the emergency department
IRCT20230302057587N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of methoxyflurane and morphine in bone fracture (Fx) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Mean pain in trauma patients. Started Apr 2023; status: completed.
02
Drugs
methoxyfluranemorphine
03
Conditions
bone fracture (Fx)
Beyond the preview
Go deeper on IRCT20230302057587N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230302057587N1.